Northern Trust’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,938
Closed -$10.7K 4492
2024
Q2
$10.7K Sell
11,938
-64
-0.5% -$74 ﹤0.01% 4376
2024
Q1
$17.8K Hold
12,002
﹤0.01% 4346
2023
Q4
$13.8K Hold
12,002
﹤0.01% 4398
2023
Q3
$25.7K Buy
12,002
+2
+0% +$5 ﹤0.01% 4285
2023
Q2
$45.9K Hold
12,000
﹤0.01% 4238
2023
Q1
$33.5K Hold
12,000
﹤0.01% 4356
2022
Q4
$32.3K Hold
12,000
﹤0.01% 4390
2022
Q3
$58K Hold
12,000
﹤0.01% 4289
2022
Q2
$127K Hold
12,000
﹤0.01% 4084
2022
Q1
$163K Hold
12,000
﹤0.01% 4198
2021
Q4
$287K Buy
+12,000
New +$283K ﹤0.01% 4040

Other funds holding BTCY

Northern Trust's BTCY Position: Q3 2024 in Review

Northern Trust sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 11,938 shares — an estimated $10.7K sold.

Northern Trust first reported a position in BTCY in Q4 2021 and held it in 11 quarters. The position peaked at $287K in Q4 2021. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

  • Northern Trust reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Northern Trust sold 11,938 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $10.7K.
  • Northern Trust first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
  • Northern Trust's Biotricity, Inc. Common Stock position peaked at $287K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on Northern Trust's 13F filing for Q3 2024, filed 13 Nov 2024.